Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis
- PMID: 20653106
- DOI: 10.1016/j.vaccine.2010.05.012
Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis
Abstract
Although multi-epitope vaccines have been evaluated for various diseases, they have not yet been investigated for lymphatic filariasis. Here, we report for the first time identification of two immunodominant B epitopes (TRXP1 and TRXP2) from the antioxidant Brugia malayi thioredoxin by studying their immune responses in mice model and human subjects. TRXP1 was also found to harbor a T epitope recognized by human PBMCs and mice splenocytes. Further, the epitopic peptides were synthesized as a single peptide conjugate (PC1) and their prophylactic efficacy was tested in a murine model of filariasis with L3 larvae. PC1 conferred a significantly high protection (75.14%) (P < 0.0001) compared to control (3.7%) and recombinant TRX (63.03%) (P < 0.018) in experimental filariasis. Our results suggest that multi-epitope vaccines could be a promising strategy in the control of lymphatic filariasis.
Similar articles
-
Chimeric Epitope Vaccine from Multistage Antigens for Lymphatic Filariasis.Scand J Immunol. 2015 Oct;82(4):380-9. doi: 10.1111/sji.12340. Scand J Immunol. 2015. PMID: 26179420
-
Epitope mapping of Brugia malayi ALT-2 and the development of a multi-epitope vaccine for lymphatic filariasis.J Helminthol. 2017 Jan;91(1):43-54. doi: 10.1017/S0022149X16000055. Epub 2016 Feb 19. J Helminthol. 2017. PMID: 26892175
-
Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis.Immunol Res. 2017 Jun;65(3):729-738. doi: 10.1007/s12026-017-8911-5. Immunol Res. 2017. PMID: 28432603
-
In-silico development of multi-epitope subunit vaccine against lymphatic filariasis.J Biomol Struct Dyn. 2025 Apr;43(6):3016-3030. doi: 10.1080/07391102.2023.2294838. Epub 2023 Dec 20. J Biomol Struct Dyn. 2025. PMID: 38117103 Review.
-
Update on immunological tests for lymphatic filariasis.Trends Parasitol. 2004 Jun;20(6):255-7. doi: 10.1016/j.pt.2004.04.002. Trends Parasitol. 2004. PMID: 15147670 Review. No abstract available.
Cited by
-
A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.Clin Microbiol Rev. 2013 Jul;26(3):381-421. doi: 10.1128/CMR.00002-13. Clin Microbiol Rev. 2013. PMID: 23824365 Free PMC article. Review.
-
Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis.PLoS One. 2013 Oct 11;8(10):e77394. doi: 10.1371/journal.pone.0077394. eCollection 2013. PLoS One. 2013. PMID: 24146990 Free PMC article.
-
Immunogenicity and Protective Efficacy of Brugia malayi Heavy Chain Myosin as Homologous DNA, Protein and Heterologous DNA/Protein Prime Boost Vaccine in Rodent Model.PLoS One. 2015 Nov 11;10(11):e0142548. doi: 10.1371/journal.pone.0142548. eCollection 2015. PLoS One. 2015. PMID: 26560102 Free PMC article.
-
Current Efficacy of Multiepitope Vaccines Against Helminths: A Systematic Review.Biomolecules. 2025 Jun 13;15(6):867. doi: 10.3390/biom15060867. Biomolecules. 2025. PMID: 40563507 Free PMC article.
-
Multivalent fusion protein vaccine for lymphatic filariasis.Vaccine. 2013 Mar 15;31(12):1616-22. doi: 10.1016/j.vaccine.2012.09.055. Epub 2012 Oct 2. Vaccine. 2013. PMID: 23036503 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous